期刊文献+

^(18)F-FDG PET/CT延迟显像数据采集参数推算方法的探讨 被引量:1

Technical aspect on calculating the acquisition parameters for delayed ^(18)F-FDG PET/CT imaging
下载PDF
导出
摘要 目的探讨 PET/CT 延迟显像需采集的总计数、计数率和采集时间的推算方法。方法对39例体格检查者行^(18)F-脱氧葡萄糖(FDG)PET/CT 全身显像,并将其全身图像分为8个区段,估算各区段总计数占全身总计数的百分比。对另25例患者分别进行早期和延迟显像,并求出其早期显像平均计数率、相应区段延迟显像每床位需采集的总计数(C_(dc))、理论推算计数率,然后启动 PET数据采集程序,记录延迟显像的实测计数率。分别以 C_(dc)除以理论推算和实测计数率,获得延迟显像理论推算和实际需要的采集时间。结果早期与延迟显像对应区段理论推算的每床位总计数、计数率和采集时间与对应的实测值间差异无统计学意义(t 值分别为-0.273、1.609和-1.692,P 值分别为0.788、0.120和0.103);3~4 h 后延迟显像采集时间较早期显像延长约2.2倍。结论该方法可避免延迟显像数据采集的随意性,提高早期与延迟显像图像质量和定量指标的可比性。 Objective The aim of the study was to verify calculation methods for the total counts, count rates and acquisition time for ^18F-fluorodeoxyglucose (FDG) PET/CT delay imaging. Methods Thirty-nine (male 26 and female 13 ) healthy subjects were scanned on Gemini PET/CT scanner after ^18F- FDG injection. Their whole body ^18F-FDG images were divided into 8 segments, from which the percentage of contribution from each segment to the total counts was calculated. Twenty-five patients ( male 15, female 10) were scanned twice, at 60 rain after ^18F-FDG injection as early phase imaging (3 min per hed) and at 3 to 4 h later as delay phase imaging. The total counts of early phase imaging were summed up and divided into each bed to calculate the average count rate per bed. Relevant regions of interest ( ROIs ) on delay phase imaging were determined by comparing the early and the delay fusion images. The theoretical total counts of the delay imaging were calculated by applying the contribution percentage of each segment from early phase imaging. Results There was no significant difference between the calculated and measured total counts, count rates and total acquisition time for the delay phase imaging (t = -0.273, P =0.788;t = 1. 609, P =0.120 ;t = - 1. 692, P =0.103, respectively). For delay phase ^18F-FDG imaging, more than 2.2 time acquisition time may be needed to achieve equivalent counts as early phase imaging. Conclusion The calculation methods could help improving the image quality and making data comparable between early phase imaging and delay phase imaging.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2007年第1期41-42,共2页 Chinese Journal of Nuclear Medicine
关键词 体层摄影术 发射型计算机 体层摄影术 X线计算机 脱氧葡萄糖 质量控制 Tomography, emission-computed Tomography, X-ray computed Deoxyglucose Quality control
  • 相关文献

参考文献8

二级参考文献31

  • 1李家敏,孙启银,杨乃明,王明芳,黄术林,张登胜,赵军,孙爱君,李娜,黄少勇.^(18)F-FDG PET显像鉴别肺部单发肿块性质及肺癌分期的价值[J].中华核医学杂志,1997,17(2):77-79. 被引量:27
  • 2陈英茂 田嘉禾.放射物理基础.正电子发射体层显像[M].北京:中国科技出版社,2001.41-42.
  • 3Demura Y, Tsuchida T, Ishizaki T, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax[J]. J Nucl Med,2003,44(4):540-548.
  • 4Kubota K, Itoh M, Ozaki K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection[J]. Eur J Nucl Med,2001,28(6):696-703.
  • 5Lodge MA, Lucas JD, Marsden PK, et al. A PET study of FDG uptake in soft tissue masses[J]. Eur J Nucl Med,1999,26(1):22-30.
  • 6Lartizien C, Comtat C, Kinahan PE, et al. Optimization of injected dose based on noise equivalent count rates for 2-and 3-dimensional whole-body PET[J].J Nucl Med, 2002,43(9):1268-1278.
  • 7Rose C, Dose J, Avril N. Positron emission tomography for the diagnosis of breast cancer. Nucl Med Commun, 2002, 23:613-618.
  • 8Tardivon AA, Guinebretiere JM, Dromain C, et al. Imaging and management of nonpalpable lesions of the breast. Eur J Radiol,2002, 42: 2-9.
  • 9Zonderland HM. The role of ultrasound in the diagnosis of breast cancer.Semin Ultrasound CT MR ,2000,21: 317-324.
  • 10Walter C, Scheidhauer K, Scharl A, et al. Clinical and diagnostie value of preoperative MR mammography and FDG PET in suspicious breast lesions. Eur Radiol, 2003, 13: 1651-1656.

共引文献87

同被引文献15

  • 1周伟,尹端沚,汪勇先.小动物PET[J].核技术,2006,29(3):207-213. 被引量:11
  • 2张雯杰,郑容,吴宁.^(18)F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值[J].国际放射医学核医学杂志,2006,30(2):94-97. 被引量:6
  • 3颜海婴,王大有.鼻咽癌放疗后局部复发和纤维化的增强 CT 鉴别诊断价值[J].中华肿瘤杂志,1997,19(3):203-205. 被引量:23
  • 4Strauss LG, Conti PS. The application of PET in clinical oncology [J]. J Nucl Med, 1991,32(4) :623-648.
  • 5Haberkom U, Strauss LG, Antonia D, et al. Fluorodeoxyglucose imaing of advanced head and neck cancer after chemotherapy [ J]. J Nucl Med, 1993,34(1) :12-17.
  • 6Mitsuhashi N, Hayakawa K, Hasegawa M, et al. Clinical FDG PET-CT in diagnosis and evaluation of radiation response of patients with nasopharyngeal tumor [ J ]. Anticancer Res, 1998,18 (4 B) :2827-2832.
  • 7Yen TC, Chang JT, Ng SH, et al. The value of ^18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx [ J ]. J Nucl Med, 2005,46 (3) :405-410.
  • 8Peng N, Yen S, Liu W, et al. Evaluation of the effect of radiation therapy to nasopharyngeal carcinoma by positron emission tomography with 2-F-18Fluoro-2-deoxy-D- glucose [ J ]. Clin Positron Imaging, 2000,3 (2) :51-56.
  • 9Molthoff CF, Klabbers BM, Berkhof J, et al. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice : comparison of 2-deoxy-2 [^18F] fluoro- D-glucose (FDG) and 3-[ ^18F] fluoro-3-deoxythymidine (FLT) [ J ]. nol hnaging Biol, 2007 (9) :340-347.
  • 10Zhuang H, Pourdehnad M, Lambright ES, et al. Dual time point ^18F-FDG PET imaing for differentiating malignant from inflammatory processes [ J]. J Nucl Med, 2001,42(9) :1412-1417.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部